- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
The mechanism of action of the drug is not dependent on absorption in the systemic circulation.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
| Gastro-oesophageal reflux |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications in children
Gaviscon suspension and sachets are high in sodium. Not to be used in situations where excessive water loss is likely, e.g. fever, diarrhoea, vomiting or high room temperature. Not to be used in gastroenteritis where the appropriate treatment is rehydration with fluid replacement.Not to be used when treating infants with known or suspected impairment of renal function as the sodium content may add to the risk of hypernatraemia.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Children with enteritis, gastroenteritis or renal insufficiency have an increased risk of hypernatraemia.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| H2-receptor antagonists | ||
|---|---|---|
| A02BA01 | ||
| A02BA03 | ||
| A02BA02 | ||
| Proton pump inhibitors | ||
|---|---|---|
| A02BC05 | ||
| A02BC01 | ||
| A02BC02 | ||
| Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | ||
|---|---|---|
| A02BX02 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
References
- Rademaker C.M.A. et al, Geneesmiddelen-Formularium voor Kinderen, 2007
- Reckitt Benckiser Healthcare (UK) Limited, SmPC Gaviscon (RVG 08401, 106364, 106116) 12-07-2021, www.geneesmiddeleninformatiebank.nl
- Nordic Drugs AB, SmPC Gaviscon (MARKEDSFØRINGSTILLATELSENUMMER 65359) 26.09.2016, www.legemiddelsok.no
- Reckitt Benckiser Healthcare (UK) Limited,, SmPC Gaviscon Infant (PL 00063/0099) 14-02-2020 (UK), www.medicines.org.uk/emc
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
